Back to Search
DR. ERIC M. SIEVERS M.D.
M.D.
Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician
NPI: 1629222427IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery Physician
Surgery
Code: 208600000X
A74936(CA)
Thoracic Surgery (Cardiothoracic Vascular Surgery) PhysicianPrimary
Thoracic Surgery (Cardiothoracic Vascular Surgery)
Code: 208G00000X
A74936(CA)7141233(TN)
Education
UNIVERSITY OF SOUTHERN CALIFORNIA KECK SCHOOL OF MEDICINE
Class of 1999
Research & Publications (20)
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial.
PMID 19557623·Leuk Lymphoma·2009
3-trial
Increase of in vivo antitumoral activity by CD40L (CD154) gene transfer into pancreatic tumor cell-dendritic cell hybrids.
PMID 19546834·Pancreas·2009
7-preclinical
A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma.
PMID 19466965·Br J Haematol·2009
3-trial
Endothelial and virgultar cell formations in the mammalian lymph node sinus: endothelial differentiation morphotypes characterized by a special kind of junction (complexus adhaerens).
PMID 19015886·Cell Tissue Res·2009
6-review
CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
PMID 18537185·Hepatology·2008
7-preclinical
Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma.
PMID 18477046·Br J Haematol·2008
7-preclinical
Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
PMID 18467731·J Clin Oncol·2008
3-trial
Pancreas carcinoma antigen fused to invariant chain elicits T-cell response and tumor growth inhibition.
PMID 18815556·Pancreas·2008
7-preclinical
[Public opinion on breast-feeding and infant nutrition: results of a questionnaire in North Rhine-Westphalia].
PMID 18368647·Gesundheitswesen·2008
8-other
Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma.
PMID 18347008·J Clin Oncol·2008
3-trial
Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.
PMID 16960154·Blood·2007
8-other
Telomerase-pulsed dendritic cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.
PMID 19675693·Ger Med Sci·2006
8-other
Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.
PMID 16734623·Clin Exp Immunol·2006
8-other
Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer.
PMID 16872953·J Thorac Cardiovasc Surg·2006
7-preclinical
A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells.
PMID 16188919·Gut·2006
8-other
Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
PMID 16584401·Liver Int·2006
4-observational
Telomerase-specific T-cells kill pancreatic tumor cells in vitro and in vivo.
PMID 16369992·Cancer·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 329 COATSLAND DR
JACKSON, TN 38301 - Phone
- (731) 424-5080
Quick Facts
- NPI
- 1629222427
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile